✦ LIBER ✦

Cetirizine: An effective agent in Kimura's disease

✍ Scribed by Ben-chetrit, Eldad ;Amir, Gail ;Shalit, Meir

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 96 KB
Volume: 53
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.20908

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Kimura's disease in a white man

✍ Urs D. A. Müller-Richter; Antonios Moralis; Tobias Reuther; Michael Kochel; Tors 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB

## Abstract ## Background Kimura's disease is a rare inflammatory disease that mainly affects Asians and most often occurs in the deep lymph nodes of the head and neck. We report on a rare case of Kimura's disease in the hard palate of a white man. ## Method A 56‐year‐old white man was seen with

Fine-needle aspiration cytology in Kimur

Fine-needle aspiration cytology in Kimura's disease

✍ Gita Jayaram; Kaik Boo Peh 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 575 KB

Aerobic conditioning: An effective thera

Aerobic conditioning: An effective therapy in McArdle's disease

✍ Ronald G. Haller; Phil Wyrick; Tanja Taivassalo; John Vissing 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

all-trans-retinoic acid in the treatment

all-trans-retinoic acid in the treatment of Kimura's disease

✍ Emmanuelle Boulanger; Bertrand Gachot; Virginie Verkarre; Françoise Valensi; Nic 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB 👁 1 views

Paclitaxel: An effective antineoplastic

Paclitaxel: An effective antineoplastic agent in the treatment of xenotransplanted hepatoblastoma

✍ Fuchs, J�rg; Habild, G�tz; Leuschner, Ivo; Schweinitz, Dietrich V.; Haindl, Joha 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 737 KB

## Background: Hepatoblastoma is an uncommon liver tumor of infancy and early childhood. though most patients with nonmetastatic hepatoblastomas can be cured by defining surgical strategies and chemotherapy regimes, new drugs are needed for children with advanced hepatoblastomas. the activity of pa

Cancer incidence in a trial of an antiap

Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease

✍ Steven R. Schwid; Janice Bausch; David Oakes; Lynn Schuchter; Caroline Tanner; M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

## Abstract We performed a placebo‐controlled trial of CEP‐1347, an inhibitor of neuronal apoptotic cell death, in patients with early Parkinson's disease (PD) to determine whether long‐term therapy would slow disability progression. This also provided an opportunity to monitor cancer incidence in